BIOVIA and Klariance, a pioneer of AI-powered workforce training compliance solutions, are partnering to ensure biopharma workforce competency evolves at the speed of science and AI. By integrating BIOVIA’s Quality and Regulatory SaaS with Klariance’s agentic training compliance platform, going beyond the limitations of traditional Learning Management Systems (LMS) to ensure a continuous audit-ready workforce, the companies are giving biopharma’s the digital thread needed to close the loop between regulated R&D and operations.
Workforce Competency at the Speed of Science and AI
As biopharmas move toward “Virtual Twins” and AI-led therapeutics R&D, the pace of innovation often outstrips the workforce’s ability to maintain compliance. This partnership addresses the critical need for a Continuous Learning Loop, where scientific advances in the lab are instantly translated into certified workforce capabilities.
By connecting Klariance directly to the BIOVIA Quality & Regulatory solution, biopharmas achieve:
- Real-Time Competency Alignment:
As new protocols or SOPs are updated within the BIOVIA QMS, Klariance automatically identifies impacted personnel and deploys hyper-personalized, role-based learning paths. - Immutable “Proof of Capability”:
To meet the rigorous standards of FDA 21 CFR Part 11 and EU GMP Chapter 2, the integrated solution creates an automated audit trail. - Predictive Compliance & Risk Mitigation:
By analyzing deviation trends within the QMS, Klariance’s agentic AI identifies “competency decay” before it leads to a non-conformance event, triggering targeted micro-learning nudges that maintain continuous audit-readiness with complete Training Records.
Cloud-Native and Differentiated
Klariance’s cloud-native architecture delivers the data liquidity required for modern biopharma. The platform uses generative AI to ingest complex regulatory updates and scientific workflows from BIOVIA and convert them into validated training modules in minutes, drastically reducing the “knowledge lag” that delays clinical and operational transitions.
📩Want to find out the latest news about BIOVIA events, customer stories, blogs and more? Join the monthly newsletter today!
Kevin is the VP of R&D for Quality & Regulatory solutions in DASSAULT SYSTEMES. As founder and former CEO of QUMAS Kevin has deep industry expertise across the Quality and Regulatory domains.